408. Role of Continuity of Care in HIV/AIDS Treatment and Care Program in Ethiopia
Session: Poster Abstract Session: HIV Engagement in Care and the Care Cascade
Thursday, October 8, 2015
Room: Poster Hall
Posters
  • Kidist Tarekegn, IDSA_poster11.pdf (231.0 kB)
  • Background: Chronic HIV care requires efficient and effective patient monitoring system to measure key indicators of patient and system performance as HIV/AIDS care and treatment program is currently transforming from emergency period into chronic care model. This study aims to assess patient monitoring and performance outcome of HIV/AIDS service in Hawassa Town, Ethiopia.

    Methods: Using cross sectional study design, data extracted by chart review of 284 sampled HIV/AIDS patients from four health facilities in Hawassa Town, Ethiopia in 2012. Data analysed using descriptive statistics and bivariate analysis to assess the effect of socio-demographic variables on outcome variables (CD4 change, weight gain, and survival). P value of 0.1 is used as a cut off point for inclusion of variables into the multivariate analysis. Prevalence ratios, adjusted prevalence odds ratios (APOR), and 95% confidence intervals were used.

    Results: CD4 count was checked in 91% of patients at baseline compared to 52% at one year. Similarly weight was measured in 96% of patients compared to 72% at one year.   Patients on Highly Active Antiretroviral Therapy (HAART) and following at hospitals had more frequent CD4 counts done and their weight measured more often than those who were not on HAART and form health centres respectively.

    HAART status was a strong predictor of CD4 improvement APOR 13.604 (CI: 4.887 - 37.873), whereas improvement in CD4 count was found to be a strong predictor of weight gain APOR 2.464 (CI: 1.016 - 5.979). HAART initiation led to an acceptable improvement in median CD4 count (from 165 (IQR 90 – 255) at baseline to 235 (IQR 152 – 335) and 275 (IQR 199 – 386) at six months and one year respectively); increased body weight (weight gain of 5kg versus 1kg among HAART patients than those not on HAART at one year); and improved functional status (from 74% patients who were able to work at baseline to 99% at 1 year). 

    Conclusion: HIV patient monitoring was robust on entry into the health system, but decreased in subsequent visits with pronounced gaps observed in health centres as opposed to hospitals and in patients on HAART versus not on HAART. We recommend a better patient monitoring and tracking system at subsequent visits specifically in health centres and for patients not on HAART

    Kidist Tarekegn, MD, Hawassa University College of Medicine and Health Science, Hawassa, Ethiopia, Shumet Lonsako, MD, MSc, MPH, Private, Hyattsville, MD and Fisseha Ghidey, MD, MPH, Infectious Diseases, Infectious Diseases Section, MedStar Washington Hospital Center, Washington DC, DC

    Disclosures:

    K. Tarekegn, None

    S. Lonsako, None

    F. Ghidey, None

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.